Company page

Brii Biosciences Limited

Brii Biosciences Limited, trading under the ticker 2137 on the Hong Kong market, has a market capitalization of approximately HKD 99.47 million. The company focuses on developing innovative therapies for infectious diseases and other serious health conditions. Brii Biosciences is committed to advancing its research and development efforts to address unmet medical needs.